ZA200900747B - Alphanizomenon flos aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disorders - Google Patents
Alphanizomenon flos aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disordersInfo
- Publication number
- ZA200900747B ZA200900747B ZA200900747A ZA200900747A ZA200900747B ZA 200900747 B ZA200900747 B ZA 200900747B ZA 200900747 A ZA200900747 A ZA 200900747A ZA 200900747 A ZA200900747 A ZA 200900747A ZA 200900747 B ZA200900747 B ZA 200900747B
- Authority
- ZA
- South Africa
- Prior art keywords
- neurodegenerative
- neurological
- treatment
- extracts
- alphanizomenon
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81659306P | 2006-06-27 | 2006-06-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200900747B true ZA200900747B (en) | 2010-05-26 |
Family
ID=38529410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200900747A ZA200900747B (en) | 2006-06-27 | 2007-06-26 | Alphanizomenon flos aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disorders |
Country Status (20)
Country | Link |
---|---|
US (1) | US9522167B2 (xx) |
EP (1) | EP2046354B1 (xx) |
JP (1) | JP5259585B2 (xx) |
KR (1) | KR20090035490A (xx) |
CN (1) | CN101478980B (xx) |
AT (1) | ATE519491T1 (xx) |
AU (1) | AU2007264042B2 (xx) |
CA (1) | CA2656154C (xx) |
DK (1) | DK2046354T3 (xx) |
ES (1) | ES2370533T3 (xx) |
HR (1) | HRP20110771T1 (xx) |
IL (1) | IL196132A (xx) |
MY (1) | MY146594A (xx) |
PL (1) | PL2046354T3 (xx) |
PT (1) | PT2046354E (xx) |
RS (1) | RS52072B (xx) |
RU (1) | RU2441663C2 (xx) |
SI (1) | SI2046354T1 (xx) |
WO (1) | WO2008000430A2 (xx) |
ZA (1) | ZA200900747B (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITTO20070391A1 (it) * | 2007-06-05 | 2008-12-06 | Medestea Res & Production S P | Composizione di integratore alimentare,farmaco o dispositivo medicale e suo impiego per sopprimere l'appetito, migliorare tono ed umore, con attivita antidepressiva naturale e con effetto antiastenico |
KR100969325B1 (ko) * | 2010-02-08 | 2010-07-09 | 인천대학교 산학협력단 | 홍조류로부터 비독성 자외선 차단용 추출물을 제조하는 방법 및 이를 이용한 비독성 자외선 차단제 |
US20140199380A1 (en) * | 2010-05-11 | 2014-07-17 | Benzion Geshuri | Pharmaceutical composition comprising an algae adapted to increase the efficacy of an enzymatic inhibitor |
US8906361B2 (en) * | 2011-03-28 | 2014-12-09 | John V. Cappello | Anti-aging formulations |
CU23963B1 (es) * | 2011-07-01 | 2013-12-11 | Ct De Ingeniería Genética Y Biotecnología | Composiciones farmacéuticas a partir de derivados de la c-ficocianina y combinaciones con interferones del tipo i para el tratamiento de enfermedades cerebrales isquémicas y neurodegenerativas |
WO2017036528A1 (en) * | 2015-09-03 | 2017-03-09 | Stefano Scoglio | Cyanobacterial microalgae, phycocyanin and phycocyanobilin to beneficially inhibit the activity of the udp-gdh enzyme while significantly increasing the absorption and circulation of curcumin |
JP6719267B2 (ja) * | 2016-04-27 | 2020-07-08 | 長瀬産業株式会社 | 安定化されたマイコスポリン様アミノ酸を含有する溶液、およびその製造方法 |
JP7257479B2 (ja) * | 2016-04-27 | 2023-04-13 | 長瀬産業株式会社 | 安定化されたマイコスポリン様アミノ酸を含有する溶液、およびその製造方法 |
JP6964707B2 (ja) * | 2016-04-27 | 2021-11-10 | 長瀬産業株式会社 | 安定化されたマイコスポリン様アミノ酸を含有する溶液、およびその製造方法 |
US20190142880A1 (en) * | 2016-05-02 | 2019-05-16 | Stefano Scoglio | The use of phycocyanins, purified or as present in cyanobacterial microalgae or extracts thereof, as prebiotics, to enhance the viability, gastrointestinal survival, pathogen-fighting ability, and the overall health-enhancing properties of probiotic cultures and products. |
EP3678743A1 (en) | 2017-09-06 | 2020-07-15 | Stefano Scoglio | The transdermal use of cyanobacterial algae, and/or extracts thereof, via low or high intensity transporation devices for beauty and health enhancing purposes |
KR102003911B1 (ko) * | 2018-02-23 | 2019-07-25 | 씨제이제일제당 주식회사 | 마이코스포린 유사 아미노산을 생산하는 미생물 및 이를 이용한 마이코스포린 유사 아미노산의 생산방법 |
CN108484438A (zh) * | 2018-03-06 | 2018-09-04 | 佛山科学技术学院 | 一种从紫菜中提取类菌胞素氨基酸的方法 |
CN108421031A (zh) * | 2018-04-13 | 2018-08-21 | 桂林医学院 | 藻蓝蛋白在制备防治帕金森病药物中的应用 |
CN108752445B (zh) * | 2018-06-20 | 2021-04-30 | 广东药科大学 | 一种螺旋藻蛋白的制备工艺及其神经保护用途 |
CN111700903B (zh) * | 2020-08-07 | 2022-03-11 | 华侨大学 | 一种紫菜多糖的应用及紫菜多糖的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5865216A (ja) * | 1981-09-16 | 1983-04-18 | Dainippon Ink & Chem Inc | 抗腫瘍剤 |
US5455276A (en) * | 1993-05-20 | 1995-10-03 | Sabelli; Hector C. | Method for treating depression |
US6814961B1 (en) * | 2001-05-14 | 2004-11-09 | Gitte S. Jensen | Method for enhancing stem cell trafficking |
BRPI0612672B8 (pt) * | 2005-06-24 | 2021-05-25 | Cerule Llc | composição de extrato aquoso de alga verde-azulada |
-
2007
- 2007-06-26 PL PL07764849T patent/PL2046354T3/pl unknown
- 2007-06-26 ZA ZA200900747A patent/ZA200900747B/xx unknown
- 2007-06-26 CN CN2007800234854A patent/CN101478980B/zh active Active
- 2007-06-26 DK DK07764849.1T patent/DK2046354T3/da active
- 2007-06-26 WO PCT/EP2007/005622 patent/WO2008000430A2/en active Application Filing
- 2007-06-26 RU RU2008151175/15A patent/RU2441663C2/ru active IP Right Revival
- 2007-06-26 MY MYPI20085257A patent/MY146594A/en unknown
- 2007-06-26 ES ES07764849T patent/ES2370533T3/es active Active
- 2007-06-26 JP JP2009516969A patent/JP5259585B2/ja not_active Expired - Fee Related
- 2007-06-26 AT AT07764849T patent/ATE519491T1/de active
- 2007-06-26 KR KR1020087031246A patent/KR20090035490A/ko not_active Application Discontinuation
- 2007-06-26 PT PT07764849T patent/PT2046354E/pt unknown
- 2007-06-26 RS RS20110480A patent/RS52072B/en unknown
- 2007-06-26 AU AU2007264042A patent/AU2007264042B2/en not_active Ceased
- 2007-06-26 CA CA2656154A patent/CA2656154C/en active Active
- 2007-06-26 SI SI200730753T patent/SI2046354T1/sl unknown
- 2007-06-26 US US12/306,483 patent/US9522167B2/en active Active - Reinstated
- 2007-06-26 EP EP07764849A patent/EP2046354B1/en active Active
-
2008
- 2008-12-23 IL IL196132A patent/IL196132A/en active IP Right Grant
-
2011
- 2011-10-24 HR HR20110771T patent/HRP20110771T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
KR20090035490A (ko) | 2009-04-09 |
PL2046354T3 (pl) | 2012-01-31 |
JP2009541388A (ja) | 2009-11-26 |
MY146594A (en) | 2012-08-30 |
US20090311286A1 (en) | 2009-12-17 |
IL196132A (en) | 2014-06-30 |
AU2007264042B2 (en) | 2012-01-12 |
SI2046354T1 (sl) | 2011-11-30 |
AU2007264042A1 (en) | 2008-01-03 |
ES2370533T3 (es) | 2011-12-19 |
ATE519491T1 (de) | 2011-08-15 |
CN101478980A (zh) | 2009-07-08 |
US9522167B2 (en) | 2016-12-20 |
CA2656154A1 (en) | 2008-01-03 |
EP2046354B1 (en) | 2011-08-10 |
CN101478980B (zh) | 2013-03-20 |
RU2441663C2 (ru) | 2012-02-10 |
RS52072B (en) | 2012-06-30 |
CA2656154C (en) | 2017-02-28 |
RU2008151175A (ru) | 2010-06-27 |
HRP20110771T1 (hr) | 2011-11-30 |
WO2008000430A3 (en) | 2008-03-27 |
EP2046354A2 (en) | 2009-04-15 |
PT2046354E (pt) | 2011-11-09 |
DK2046354T3 (da) | 2011-10-31 |
IL196132A0 (en) | 2009-09-22 |
JP5259585B2 (ja) | 2013-08-07 |
WO2008000430A2 (en) | 2008-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200900747B (en) | Alphanizomenon flos aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disorders | |
WO2007121188A3 (en) | Compositions and methods of using r(+) pramipexole | |
TNSN08400A1 (en) | Organic compounds and their uses | |
WO2007038610A3 (en) | Use of natural products for treatment of neurological disorders | |
TN2010000137A1 (en) | Spiropyrrolidines and their use against hcv and hiv infection | |
WO2006119295A3 (en) | Compositions and methods for the treatment of neurodegenerative diseases | |
MY149492A (en) | Immunoglobulins directed against nogo | |
MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
WO2007130383A3 (en) | Compositions and treatments using pyridazine compounds and secretases | |
MX2007009356A (es) | Compuestos y composiciones como moduladores de ppar. | |
WO2008000513A3 (en) | Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction | |
MY158325A (en) | Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection | |
TW200800976A (en) | New compounds for the treatment of neurological, psychiatric or pain disorders | |
WO2005112976A3 (en) | Probiotic compounds from lactobacillus gg and uses therefor | |
MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
EP2152865A4 (en) | METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS | |
EP2069377A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES AND SKIN FUNCTIONAL DISORDERS | |
UA96926C2 (ru) | Применение sdf-1 для лечения и/или профилактики неврологических заболеваний | |
EA201101579A1 (ru) | Имидазо[1,2-а]пиридин-2-ил-фенил производные для лечения рака | |
TW200621799A (en) | Acylated nonadepsipeptides II | |
SG162829A1 (en) | Humanised antibodies specific for nogo-a and pharmaceutical uses thereof | |
WO2008039409A3 (en) | Methods and kits for use in the treatment and prevention of diseases or conditions of the immune system or infectious diseases | |
IL194353A0 (en) | Lysobactin amides | |
WO2010083311A3 (en) | Compositions and methods of use | |
IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases |